Drawing for CORE BIOGENESIS

USPTO serial 79365664

CORE BIOGENESIS

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
Examiner
HOWARD, PARKER WALDRIP
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CORE BIOGENESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R. Robinson

James R. Robinson Robinson Law Office, PLLC13 Loyola DriveHot Springs Village, AR 71909UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, namely, proteins and other molecules for use in industry and science; proteins and other molecules used for manufacturing or as ingredients of foodstuffs for human and animal consumption, and food supplements for human and animal consumption; proteins and other molecules for use in medical research; proteins and other molecules used as industrial chemicals for manufacturing or as ingredients in cell culture media and diagnostic preparations; proteins and other biomolecules used for manufacturing or as ingredients of pharmaceuticals (biopharmaceuticals); enzymes and other molecules for industrial and scientific use; biological preparations for use in industry and science; cell growth media for growing cells and for use in scientific, biological and biotechnological research; biological preparations, namely, fats and lipids, proteins, peptides, living cells, living tissue, laboratory-grown living cells, laboratory-grown living tissue for use in industry and scienceACTIVE
005Pharmaceutical and veterinary products; stem cells for medical, clinical, pharmaceutical and veterinary use; cell growth media for growing cells for medical, clinical, pharmaceutical and veterinary use; chemical preparations for medical, clinical, pharmaceutical and veterinary use; biological preparations for medical, clinical, pharmaceutical and veterinary use; bacterial preparations for medical, clinical, pharmaceutical and veterinary use; microbiological culture media for medical, clinical, pharmaceutical and veterinary use; enzyme preparations for medical, clinical, pharmaceutical and veterinary use; diagnostic preparations for medical, clinical, pharmaceutical and veterinary use; biological products in the nature of cell preparations for medical, clinical, pharmaceutical and veterinary useACTIVE
010Apparatus for the regeneration of stem cells for medical useACTIVE
029Meat, fish, poultry, game and synthetic substitutes; protein powder for use as a nutritional additive (food supplements)ACTIVE
042Chemical research; scientific research; biological research; chemical analysis; molecular research; genetic research; cell researchACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 9, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 8, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 8, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 21, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 21, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 6, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
May 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 28, 2024GNSLLETTER OF SUSPENSION E-MAILED
Feb 28, 2024CNSLSUSPENSION LETTER WRITTEN
Nov 28, 2023CNSLSUSPENSION LETTER WRITTEN
Nov 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2023RFNPREFUSAL PROCESSED BY IB
Sep 15, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2023RFRRREFUSAL PROCESSED BY MPU
Aug 24, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 23, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2023RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jul 29, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2023DOCKASSIGNED TO EXAMINER
Mar 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Mar 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance